SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-15-000365
Filing Date
2015-04-01
Accepted
2015-03-31 17:35:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A, AMENDMENT #1 s14176685a.htm SC 13D/A 28842
2 NOMINATION AND STANDSTILL AGREEMENT s14176685b.htm EX-1 167123
  Complete submission text file 0000899140-15-000365.txt   197597
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85739 | Film No.: 15740611
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD 3RD FLOOR GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD 3RD FLOOR GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

IRS No.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A